hydrochlorothiazide-triamterene has been researched along with Hyperkalemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hollenberg, NK; Mickiewicz, C | 1 |
| Bannon, JA; Hollenberg, NK | 1 |
| Houston, MC; Johnston, PE | 1 |
1 review(s) available for hydrochlorothiazide-triamterene and Hyperkalemia
| Article | Year |
|---|---|
Essential hypertension: new insights and controversies in treatment with diuretics.
Topics: Amiloride; Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Furosemide; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Lipoproteins, LDL; Magnesium; Potassium; Potassium Chloride; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Triglycerides | 1986 |
1 trial(s) available for hydrochlorothiazide-triamterene and Hyperkalemia
| Article | Year |
|---|---|
The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
Topics: Age Factors; Antihypertensive Agents; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Hypokalemia; Male; Middle Aged; Prospective Studies; Triamterene; United States; Uremia | 1986 |
1 other study(ies) available for hydrochlorothiazide-triamterene and Hyperkalemia
| Article | Year |
|---|---|
Hyperkalemia in diabetes mellitus. Effect of a triamterene-hydrochlorothiazide combination.
Topics: Diabetes Complications; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Triamterene | 1989 |